Get straight to the point with our proprietary CHOZN® platform
|Expression||Molecule Type||M & F Screening||Process Development||Production Scale|
|DHFR||Fc-Fusion||✓||✓||250L – 1,250L|
|GS||Monoclonal antibody||✓||✓||250L – 1,250L|
|Biowa||Monoclonal antibody||✓||✓||250L – 1,250L|
|CHEF 1||Monoclonal antibody||✓|
|GS||Monoclonal antibody||✓||✓||20L – 2,000L|
|M||Selexis||Monoclonal antibody||✓||✓||20L – 2,000L|
|Horizon||GS||Monoclonal antibody||✓||200L – 2,000L|
|Host||Molecule Type||M & F Screening||Process Development||Production Scale|
Guidebook: Break Down Roadblocks to Clinical Success
The key to this success is to make the right decisions at the right time. In this guidebook, our experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety.
Case Study: Accelerate Time from DNA to Material
Learn how our approach to mini pools allows us to deliver high-producing clones in an accelerated timeline, saving up to 3 months. In addition, we are able to begin process development in parallel with cell line development for clients with very challenging timelines.
Brochure: Plug & Play Upstream Development Service
A service exactly tailored to small-sized biotechs and start-ups, needing to balance cost and speed to clinic while getting it right the first time.